相关实验视频

Updated: Apr 29, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

TEDML:一种新的机器学习 (ML) 方法用于预测甲状腺眼病和识别关键生物标志物

Jing Zhu, Shu Zhu, Bin Liu

The Journal of endocrinology

|March 3, 2025

概括

甲状腺眼病 (TED) 涉及免疫细胞的变化和代谢问题. 研究人员开发了一个准确的预测模型 (TEDML),识别了像CSF3R这样的关键生物标志物,为有针对性的TED疗法提供了新的途径.

科学领域:

眼科医生眼科眼科
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

甲状腺眼病 (TED) 的特点是免疫透和代谢失调.
识别诊断和治疗生物标志物对于管理TED至关重要.

研究的目的:

在TED中分析免疫细胞透和代谢途径.
在TED中开发一个用于识别关键生物标志物的预测模型.
为了探索TED的潜在治疗药物.

主要方法:

在TED数据集 (GSE58331,GSE105149) 上进行免疫细胞透分析和基因组变异分析 (GSVA).
使用113个算法开发一个机器学习预测模型 (TEDML).
丰富和药物敏感性分析.

主要成果:

TED表现出改变的免疫细胞概况 (增加CD4+ Tem,CD4+ Tcm,NKT,NK,中性粒细胞;减少M1/M2巨细胞).
GSVA显示了免疫和代谢途径的显著丰富.
该TEDML模型准确地预测了TED,识别了六个关键基因 (CSF3R,ALDH1A1,MXRA5,VSIG4,DPP4,MDH1).
CSF3R被强调为潜在的治疗标,其中阿扎西奥普林和甲基普雷迪尼索隆显示出潜在的疗效.

结论:

TEDML模型为TED生物标志物识别提供了一个可靠的工具.
CSF3R成为TED的重要生物标志物,与治疗策略相关.
这些发现为甲状腺眼病的向治疗提供了新的见解.

关键词:

在TEDML模型模型中.生物标志物生物标志物免疫透免疫透是什么?机器学习是机器学习.甲状腺眼睛疾病甲状腺眼睛疾病

更多相关视频

A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images

A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images

Published on: April 21, 2023

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

相关概念视频

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...